GBS vaccine (Minervax)

N/A

Report date: 2024/09/25 20:00:35

Base Information

Drug NameGBS vaccine (Minervax)
Drug Alias NameGroup B Streptococcal vaccine (Minervax)Streptococcal B vaccine (Minervax)GBS-NN
ClassificationVaccines > Development/production technology > Inactivated vaccine > Subunit vaccineVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningitisNeonatal SepsisPneumonia +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumSouth AfricaDenmark +[4] 
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesMinervax Aps
China Registration ClassN/A

Develop Information

Active CompaniesMinervax Aps
Inactive CompaniesN/A
Active IndicationsMeningitisNeonatal SepsisPneumonia +[7] 
Inactive IndicationsInfections

Other Information

ATC CodeN/A
Related LinksN/A